Effects of dextrose and corticostroid on plantar fasciitis treatment

Phase 2

• Conditions: Plantar fasciitis.; Diseases of the musculoskeletal system and connective tissue

• Registration Number: IRCT2015041321744N1
• Lead Sponsor: Vice Chancellor for research of Iran University Of Medical Science

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Inclusion: a history of plantar fasciitis;heel pain for more than 2 months with a VAS(visual Analogue Scale) more than 4;fascia hypoechogenisity and thickness more than 4 mm in sonography

exclusion:a history of direct trauma; positive tinnel sign; a history of systemic inflamatory or soft tissue diseases; disk herniation with S1 radiculopathy; a history of gout; diabetes melitus; a history of surgury or injection in fascia since 6 months ago, existence of cyst/mass in pain site; coincidence of paresthesia or numbness; coagolupathy; pregnancy; hypersensitivity to corticosteroids; infection of injection site, posterior heel pain; any treatment for the condition since 4 weeks ago; patients who receive physiotherapy, splint, Ionophoresis and shockwave during 2 months after injection

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain. Timepoint: Before injection, 2 weeks and 8 weeks after injection. Method of measurement: Visual Analog Scale(VAS).;Daily living and sport activity. Timepoint: before injection,2 weeks and 8 weeks after injection. Method of measurement: FAAM questionaire.

Secondary Outcome Measures

Name	Time	Method
Thickness of plantar fascia. Timepoint: before injection, 2 weeks and 8 weeks after injection. Method of measurement: sonography.